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Chemotherapy-induced mucositis can limit the effectiveness of cancer therapy and 
increase the risk of infections. However, no specific therapy for protection against 
mucositis is currently available. In this study, we investigated the therapeutic effect of 
PLAG (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol, acetylated diglyceride) in 5-fluoro-
uracil (5-FU)-induced oral mucositis animal models. Hamsters were administered 5-FU 
(80  mg/kg) intraperitoneally on days 0, 6, and 9. The animals’ cheek pouches were 
then scratched equally with the tip of an 18-gage needle on days 1, 2, and 7. PLAG 
was administered daily at 250  mg/kg/day. PLAG administration significantly reduced 
5-FU/scratching-induced mucositis. Dramatic reversal of weight loss in PLAG-treated 
hamsters with mucositis was observed. Histochemical staining data also revealed 
newly differentiated epidermis and blood vessels in the cheek pouches of PLAG-treated 
hamsters, indicative of recovery. Whole blood analyses indicated that PLAG prevents 
5-FU-induced excessive neutrophil transmigration to the infection site and eventually 
stabilizes the number of circulating neutrophils. In a mouse mucositis model, mice with 
5-FU-induced disease treated with PLAG exhibited resistance to body-weight loss com-
pared with mice that received 5-FU or 5-FU/scratching alone. PLAG also dramatically 
reversed mucositis-associated weight loss and inhibited mucositis-induced inflammatory 
responses in the tongue and serum. These data suggest that PLAG enhances recovery 
from 5-FU-induced oral mucositis and may therefore be a useful therapeutic agent for 
treating side effects of chemotherapy, such as mucositis and cachexia.
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inTrODUcTiOn
Oral mucositis is a common complication of chemotherapy and is often accompanied by erythema, 
ulceration, pain, weight loss, and delayed remission (1). Chemotherapy-induced mucositis occurs in 
40–70% of patients and can limit the anticancer effects of chemotherapy, thus extending the thera-
peutic period and potentially reducing survival (2). Mucositis is defined as damage and inflammation 
in the mucous membranes lining the gastrointestinal tract (3). Chemotherapy can induce epithelial 
damage, which can then lead to a significant increase in inflammatory cytokine and chemokine secre-
tion and activation of neutrophil extravasation (4). Neutrophils are the first leukocytes recruited to 
Table 1 | Mucositis scoring criteria [from sonis et al. (16)].
score Parameter
0 Completely healthy cheek pouch with no erosion or vasodilatation
1 Presence of erythema, but no evidence of erosion in the cheek 
pouch
2 Severe erythema, vasodilation, and surface erosion
3 Formation of ulcers in one or more faces of the mucosa, but not 
affecting more than 25% of the surface area of the cheek pouch, 
as well as severe erythema and vasodilatation
4 Cumulative formation of ulcers of about 50% of the surface area of 
the cheek pouch
5 Complete ulceration of the cheek pouch mucosa, in which the 
fibrosis makes oral mucosa exposure difficult
2
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infected tissue, where they function to eliminate pathogens (5). 
Neutrophils destroy pathogen cells via phagocytosis, degranula-
tion, and the neutrophil extracellular trap (NET) (6, 7). Although 
neutrophils play a critical role in the innate immune system, 
excessive transmigration of neutrophils can result in neutropenia 
and severe inflammation in the host tissue (8). Mucositis may, 
therefore, limit the effectiveness of chemotherapy, resulting in 
an extension of the treatment period and perhaps a decrease in 
patient survival (9).
The anti-metabolite drug 5-fluorouracil (5-FU) is widely used 
for the treatment of solid tumors, including colorectal and breast 
cancers (10). 5-FU is an analog of uracil that non-specifically 
blocks DNA synthesis, thus inhibiting cell division (11). PLAG 
(1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) is an acetylated 
form of diacylglycerol and a mono-acetyl-diglyceride that was 
first isolated from the antlers of sika deer (12). PLAG can be 
chemically synthesized using glycerol, palmitic acid, and linoleic 
acid, and the synthetic form has been confirmed to be identical 
with the naturally isolated form (13). In a previous study, PLAG 
was shown to exert a therapeutic effect with pegfilgrastim to treat 
chemotherapy-induced neutropenia by modulating neutrophil 
transmigration (14). Because PLAG regulates neutrophil trans-
migration, we hypothesized that PLAG administration would 
ameliorate the sequelae associated with oral mucositis.
To characterize the effect of PLAG on oral mucositis, we 
established oral mucositis models in mice and hamsters in which 
the disease is induced by 5-FU administration and scratching of 
the cheek pouches and/or tongue with the tip of an 18-gage nee-
dle (15). The scratching increases the risk of infection and thus 
induces neutrophil recruitment into the inflamed tissues. Using 
these models, we found that PLAG administration significantly 
reduced the symptoms of oral mucositis. PLAG reversed the 
weight loss, ulceration, and severe inflammation associated with 
5-FU/scratching-induced mucositis. These data indicate that 
PLAG could be therapeutically useful in reducing the complica-
tions associated with chemotherapy, such as oral mucositis and 
cachexia, and thus may be an excellent supplementary agent for 
anticancer therapy.
MaTerials anD MeThODs
animal experiments
Male Syrian Golden Hamsters were obtained from Japan SLC 
(Shizuoka Prefecture, Japan). The hamsters were 6  weeks old, 
weighed 120–140 g, and were maintained under specific pathogen-
free conditions. BALB/c mice were obtained from Koatech Co. 
(Pyongtaek, Republic of Korea) and maintained under specific 
pathogen-free conditions. The mice were 6–8 weeks of age and 
weighed 20–22 g at the time of the experiments.
All animal experimental procedures were performed in 
accordance with the Guide for the Care and Use of Laboratory 
Animals (Institute of Laboratory Animal Resources). 
ethics statement
All experiments were approved by the Institutional Review 
Committee for Animal Care and Use of KRIBB (Korea 
Research Institute of Bioscience and Biotechnology, Daejeon, 
Republic of Korea).
Oral Mucositis experimental Models
Hamsters were intraperitoneally administered 5-FU (Sigma 
Aldrich, MO, USA) at 80 mg/kg on days 0, 6, and 9. For the scratch-
ing group, hamsters were anesthetized with 2,2,2-tribromoetha-
nol (150 mg/kg, Sigma Aldrich) by intraperitoneal injection, and 
then a 1-cm2 area of each cheek pouch was scratched with the tip 
of an 18-gage needle (Koreavaccine, Aansan, Republic of Korea) 
at an equal force and depth on days 1, 2, and 7. The scratching 
was blinded to the treatment groups (n = 3 per group). PLAG 
(Enzychem Lifesciences Co., Daejeon, Republic of Korea) was 
then administered orally at 250 mg/kg/day.
Mice were intraperitoneally administered 5-FU (Sigma 
Aldrich) at 100 mg/kg on day 0. For the scratching group, mice 
were anesthetized with 2,2,2-tribromoethanol (150 mg/kg, Sigma 
Aldrich) by intraperitoneal injection, and then a 0.5-cm2 area 
of the tongue was scratched using the tip of an 18-gage needle 
(Koreavaccine) at an equal force and depth on days 7 and 8. The 
scratching was blinded to the treatment groups (n = 5 per group). 
PLAG (Enzychem Lifesciences) was then administered orally at 
250 mg/kg/day beginning on day 7.
assessment of Mucositis
Mucositis was scored by a blinded investigator using published 
criteria based on the following parameters: erythema, vasodila-
tion, erosion, bleeding, fibrosis, and ulcers (Table 1) (16).
hematoxylin and eosin staining
Samples of cheek pouch tissue were obtained on day 13, fixed 
in 10% buffered formalin for 24  h, embedded in paraffin, and 
sectioned at a thickness of 4 μm. The tissue sections were stained 
with hematoxylin and eosin (H&E), and the degree of inflamma-
tory cell infiltration was assessed. Sections were observed under 
a light microscope (Olympus, Tokyo, Japan).
Peripheral blood analysis
For hamsters, whole blood was collected from the orbital sinuses 
using capillary tubes (Kimble Chase Life Science and Research 
Products LLC, FL, USA) and collection tubes (Greiner Bio-One 
International, Frickenhausen, Germany) containing K3E-
K3EDTA. Blood cells were enumerated by CBC analysis using 
FigUre 1 | The hamster mucositis model. Hamsters were divided into four groups (n = 3 per group): (1) control group, (2) 5-FU treatment group,  
(3) scratching/5-FU treatment group, and (4) scratching/5-FU/PLAG treatment group (a). 5-FU was administered intraperitoneally at 80 mg/kg on days 0, 6, and 9. 
PLAG was administered orally at 250 mg/kg/day. For the scratching model, hamsters were anesthetized and the cheek pouches were scratched with an equal force 
and depth on days 1, 2, and 7. The cheek pouches were isolated on day 13 (b). The volume (c) and weight (D) of the isolated cheek pouches were measured. 
Mucositis scores were determined on days 2, 7, 11, and 13 (e). ▬, control; ▲, 80 mg/kg 5-FU; X–, scratching with 80 mg/kg 5-FU; and ●, scratching with 80 mg/
kg 5-FU and 250 mg/kg PLAG. Average values are shown, and the bars represent error ranges. Statistical significance was assessed using Student’s t-test.
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a BC 5300 Mindray analyzer (Shenzhen Mindray Bio-medical 
Electronics, China).
elisa
The concentrations of interleukin (IL)-6, tumor necrosis factor 
(TNF), and IL-1β in the supernatant of homogenized tongue, 
and serum samples were measured using a mouse IL-6 ELISA 
kit, mouse TNF ELISA kit, and mouse IL-1β ELISA kit (all 
from BD Bioscience, NJ, USA), respectively, according to the 
manufacturer’s instructions. The cytokine levels were estimated 
by interpolation from a standard curve generated using an ELISA 
reader (Molecular Devices) at a wavelength of 450 nm.
statistical analyses
Statistical analyses were performed using paired Student’s t-tests. 
Differences were considered statistically significant at p < 0.001, 
p < 0.01, and p < 0.05.
resUlTs
Plag alleviated the symptoms of severe 
Mucositis in the hamster Model
To investigate whether PLAG has a therapeutic effect on 
5-FU-induced mucositis in the hamster model, 5-FU was intra-
peritoneally administered on days 0, 6, and 9 (Figure 1A). The 
cheek pouches were scratched equally on days 1, 2, and 7, and 
PLAG was administered orally every day thereafter. To quantify 
the level of oral mucositis, the cheek pouches were isolated on 
day 13. The 5-FU/scratching group exhibited severe ulceration, 
fibrosis, and festering wounds (Figure 1B). PLAG treatment sig-
nificantly decreased ulcer formation and diminished the degree 
of wound festering. No fibrosis was observed in the cheek pouches 
of PLAG-treated hamsters. Inflammation of cheek pouches 
induced by 5-FU/scratching was ameliorated by PLAG adminis-
tration, which significantly decreased the volume and weight of 
isolated pouches (Figures 1C,D). PLAG administration also had 
FigUre 2 | body weight in the hamster mucositis model. (a) The groups of hamsters (n = 3 per group) were treated as described for Figure 1a, and body 
weight was recorded daily. (b) The body weight of hamsters was evaluated on day 13. ▬, control; ▲, 80 mg/kg 5-FU; X–, scratching with 80 mg/kg 5-FU; and ●, 
scratching with 80 mg/kg 5-FU and 250 mg/kg PLAG. Average values are shown, and the bars represent error ranges. Statistical significance was assessed using 
Student’s t-test.
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an effect on the mucositis score (Figure 1E). Compared with the 
5-FU/scratching group, PLAG-treated hamsters exhibited a lower 
mucositis score (p < 0.01). These data indicate that PLAG has a 
significant therapeutic effect against chemotherapy-induced oral 
mucositis.
Plag administration reversed Weight 
loss in the hamster Mucositis Model
Cancer patients usually experience a decline in body weight 
and difficulty in eating. This condition, known as cachexia, is 
associated with a poor therapeutic prognosis (17). To charac-
terize the effect of PLAG on mucositis-associated cachexia, the 
body weight of hamsters was monitored. PLAG administration 
had a significant effect in preventing weight loss associated 
with 5-FU/scratching-induced mucositis (Figure 2A). By day 
13, hamsters in the 5-FU/scratching group exhibited a 15% 
decline in body weight compared to controls (Figure  2B). 
Hamsters subjected to 5-FU/scratching and PLAG administra-
tion lost only 5% of their body weight. These results suggest that 
chemotherapy-associated cachexia may be prevented by PLAG 
administration.
Plag administration suppressed 
Mucositis-induced inflammation  
in hamsters
For histopathologic analysis, isolated hamster cheek pouches 
were stained with H&E. Hamsters in the 5-FU/scratching 
group exhibited dermal necrosis and severe fibrosis, with an 
increase in the thickness of the mucosal epidermis (Figure 3). 
Hamsters subjected to 5-FU/scratching and PLAG administra-
tion exhibited newly formed epidermis and blood vessels in the 
cheek pouches, indicative of recovery. These data also suggest 
that PLAG is useful for treating or preventing chemotherapy-
induced oral mucositis.
FigUre 3 | histopathologic analysis of hamster cheek pouches. The groups of hamsters were treated as described for Figure 1a. After 13 days, the cheek 
pouches were isolated and stained with H&E. Tissue sections were examined under a light microscope (100× and 200×). Representative images of the sections are 
presented.
FigUre 4 | circulating neutrophils in the hamster mucositis model. Groups of hamsters (n = 3 per group) were treated as described for Figure 1a. Whole 
blood was collected, and the number of circulating neutrophils was determined on days 0, 7, 9, and 11 (a). Neutrophils were evaluated on day 11 (b). ▬, control; 
▲, 80 mg/kg 5-FU; X–, scratching with 80 mg/kg 5-FU; and ●, scratching with 80 mg/kg 5-FU and 250 mg/kg PLAG. Average values were calculated. The bars 
represent error ranges. Statistical significance was assessed using Student’s t-test.
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Plag administration Prevented  
5-FU-induced excessive neutrophil 
Transmigration into scratched Tissues  
in the hamster Mucositis Model
Circulating blood cells were counted on days 7, 9, and 11. The 
neutrophil count was significantly reduced by 5-FU treatment 
and steadily declined in hamsters subjected to 5-FU/scratching 
(Figure 4A). Hamsters that received PLAG with 5-FU/scratching 
had a greater number of neutrophils than hamsters treated with 
5-FU alone or 5-FU/scratching alone. Moreover, the number 
of circulating neutrophils in 5-FU/scratching hamsters treated 
with PLAG was similar to that of control animals (Figure 4B). 
These findings indicate that PLAG plays a role in reversing the 
FigUre 5 | changes in body weight of mice in the 5-FU-induced mucositis model. Mice were divided into four groups (n = 5 per group): (1) control,  
(2) 5-FU treatment, (3) scratching/5-FU treatment, and (4) scratching/5-FU/PLAG treatment (a). 5-FU was administered intraperitoneally at 100 mg/kg on day 0. For 
the scratching group, mice were anesthetized and the tongue was scratched equally on days 7 and 8. PLAG was orally administered at 250 mg/kg/day beginning 
on the day of scratching for 8 days. Body weight was recorded daily (b). ▬, control; ▲, 100 mg/kg 5-FU; X–, scratching with 100 mg/kg 5-FU; and ●, scratching 
with 100 mg/kg 5-FU and 250 mg/kg PLAG. The body weight of mice was evaluated on day 15 (c). The tongues were evaluated on day 15 (D). Average values 
were calculated, and the bars represent error ranges. Statistical significance was assessed using Student’s t-test.
6
Lee et al. PLAG Prevents Mucositis and Cachexia
Frontiers in Oncology | www.frontiersin.org October 2016 | Volume 6 | Article 209
decline in the number of circulating neutrophils associated with 
chemotherapy-induced neutropenia.
Plag administration reversed Weight 
loss and cured Ulceration in the Mouse 
Mucositis Model
Treatment of hamster subjected to 5-FU/scratching with PLAG 
prevented the progression of oral mucositis. To investigate the 
therapeutic effect of PLAG in mice, the animals were administered 
5-FU on day 0, and after 7 days, PLAG was orally administered 
with scratching of the tongue (Figure  5A). After scratching, 
the mice exhibited a rapid and significant loss of body weight 
(Figure 5B). However, in mice also treated with PLAG, the body 
weight returned to the control level by day 15 (Figure 5C).
Figure  5D shows that 5FU/scratching resulted in severe 
ulceration of the tongue. In PLAG-treated mice, however, the 
scratching did not lead to ulceration. These data suggest that 
PLAG is a useful therapeutic agent for treating side effects of 
chemotherapy such as mucositis and cachexia.
Plag administration Diminished 
Mucositis-induced inflammatory 
response in the Tongue and serum  
of Mice
To determine whether PLAG has an anti-inflammatory effect 
in mice with oral mucositis, levels of various chemokines were 
measured in the supernatant of homogenized tongue tissue 
and serum. Levels of the representative inflammatory cytokine 
IL-6 increased as a result of 5-FU/scratching treatment but 
were significantly reduced in both the tongue (Figure 6A) and 
serum (Figure  6B) following PLAG administration. PLAG 
7Lee et al. PLAG Prevents Mucositis and Cachexia
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FigUre 6 | levels of proinflammatory cytokines in the tongue and serum. The groups of mice were treated as described for Figure 5a. On day 15, the 
tongue and serum were obtained from the mice in each group. The secreted levels of IL-6, TNF, and IL-1β were determined in the supernatant of homogenized 
tongue tissue (a) and serum (b) using an ELISA.
administration also resulted in decreases in the levels of TNF in 
the serum and IL-1β in the tongue. These data indicate that PLAG 
plays an anti-inflammatory role and could therefore be a useful 
therapeutic agent for treating mucositis-associated inflammation.
DiscUssiOn
We previously reported that PLAG administration efficiently 
blocks neutrophil extravasation and increases the number of 
circulating neutrophils when used with pegfilgrastim during 
gemcitabine treatment (14). These data suggest that PLAG exerts 
a therapeutic effect with pegfilgrastim on chemotherapy-induced 
neutropenia by regulating neutrophil transmigration. In cancer 
patients, inflammation is regarded as a critical factor indicative 
of tumor malignancy or chronic inflammation-induced sepsis 
(18, 19). To characterize the effect of PLAG on the severity of 
inflammation associated with chemotherapy, mucositis indexes 
were evaluated in the induced oral mucositis hamster and mouse 
models. As shown in Figure 1, mucositis scores and the volume 
and weight of cheek pouches in the animals subjected to 5-FU/
scratching treatment were increased and significantly decreased, 
respectively, following PLAG administration. This indicates that 
neutrophil activation for transmigration is induced by 5-FU/
scratching treatment and could result in increased neutrophil 
infiltration with subsequent formation of ulcers (i.e., mucositis). 
Moreover, histochemical staining data showed that the dermal 
necrosis induced by 5-FU/scratching was alleviated by PLAG 
administration (Figure  3). PLAG, therefore, appears to block 
neutrophil recruitment and minimize the mucositis burden by 
preventing excessive neutrophil transmigration into the scratched 
tissues.
Cachexia is a complication associated with both cancer 
chemotherapy and mucositis. Tumor-induced inflammatory 
molecules can affect host metabolism, leading to apoptosis (20). 
Although the incidence of cachexia is high in cancer patients, 
there is no specific medicine available for treating the condi-
tion. PLAG has the potential to not only prevent the weight loss 
induced by mucositis but also to promote the recovery of lost 
body weight (Figures  2 and 5). Both the viability and ease of 
movement in PLAG-treated mice was much better than that of 
8Lee et al. PLAG Prevents Mucositis and Cachexia
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mice subjected to 5-FU/scratching alone. Further studies are 
needed to reveal how PLAG affects metabolism and physical 
activity.
A direct association exists between inflammation and the 
acceleration of cancer malignancy and neutrophil transmigra-
tion following chemotherapy (18, 19). Mice treated with 5-FU 
exhibited diarrhea associated with the significant increases in 
colon chemokine levels, including levels of CXCL1, 2, and 3 as 
well as neutrophil recruitment (21). The biomarker for cachexia 
also included inflammatory cytokines (22). We found that PLAG 
reduced lipopolysaccharide-induced myeloperoxidase activity 
and neutrophilic inflammation-related gene expression in an 
acute lung injury mouse model (data not shown). In this study, 
we verified that PLAG plays an anti-inflammatory role in chem-
otherapy-induced oral mucositis and, subsequently, promotes the 
healing of ulceration and reduces inflammation (Figures 1 and 
5). PLAG administration also significantly reduced the expres-
sion of inflammatory cytokines (IL-6, TNF, and IL-1β) induced 
by 5-FU/scratching in the tongue and serum in the mouse model 
(Figure  6). These data demonstrate that PLAG exerts an anti-
inflammatory effect in the induced oral mucositis hamster and 
mouse models. Therefore, PLAG could be a useful adjuvant for 
treating chemotherapy-induced side effects via modulation of 
neutrophil migration.
aUThOr cOnTribUTiOns
JWK and SY designed the project and prepared the manuscript. 
H-RL and NY performed in vivo assay, ELISA assay, and data 
collection. The manuscript was completed by H-RL. IHC were 
performed and analyzed by JHK. Experiments for functional 
analysis were analyzed by K-YS, H-JK, and M-HK. MYH ana-
lyzed the result of animal experiment and provided scientific 
expertise. All authors discussed the results and commented on 
the manuscript.
FUnDing
This work was supported by the KRIBB Research Initiative 
Program (KGM5251611), grants (IGM0121611 and IGM0131611) 
from ENZYCHEM Lifesciences, and a grant (KDDF-201410-10) 
by Korean Drug Development Fund (KDDF).
